CALCA and migraine disorder: Although new preventive therapies for migraine, the Calcitonin Gene-Related Peptide monoclonal antibodies (CGRP mAbs), have proven to be very effective, some patients did not respond optimally; this is the case of overweight patients with migraine [2].